Related Experiment Video
Updated: Jun 25, 2025

Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
Buprenorphine Use for Analgesia in Palliative Care
Leanne K Jackson1,2, Ivy O Poon3,4, Mary A Garcia1,2
1Rehabilitation & Extended Care Line, Section of Palliative Medicine, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA.
Buprenorphine, a partial µ-opioid receptor agonist, offers effective chronic pain relief with fewer side effects than full agonists. Its potential in palliative care is hindered by stigma, despite its unique pharmacological advantages.
Area of Science:
- Pharmacology
- Pain Management
- Palliative Care
Background:
- Buprenorphine is a long-acting partial µ-opioid receptor (MOR) agonist.
- Available as sublingual tablets, transdermal patches (Butrans®), or buccal films (Belbuca®).
- Underused in chronic pain and palliative care due to misconceptions and stigma associated with opioid use disorder (OUD).
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Parenteral Anesthetics: Overview
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Drugs for Treatment of Constipation-Predominant IBS

